2020
DOI: 10.1016/j.bpj.2020.10.028
|View full text |Cite
|
Sign up to set email alerts
|

The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
2

Relationship

5
5

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 68 publications
2
14
0
Order By: Relevance
“…5d, e ). This change in conformation of complex II after associating with Rab5a on membranes is consistent with the recent, elegant study of VPS34 complex II by single-molecule kinetics that showed that Rab5a coupled to membranes both increases the density of complex II on membranes and increases the specific activity of complex II on Rab5a membranes relative to membranes without Rab5 54 . While it is clear that a significant component of the increase in activity of complex I on Rab1a-coupled membranes and complex II on Rab5a-coupled membranes is due to enhanced recruitment, the conformational changes in VPS34 seen in the cryo-ET suggest that activation involves multiple steps.…”
Section: Discussionsupporting
confidence: 90%
“…5d, e ). This change in conformation of complex II after associating with Rab5a on membranes is consistent with the recent, elegant study of VPS34 complex II by single-molecule kinetics that showed that Rab5a coupled to membranes both increases the density of complex II on membranes and increases the specific activity of complex II on Rab5a membranes relative to membranes without Rab5 54 . While it is clear that a significant component of the increase in activity of complex I on Rab1a-coupled membranes and complex II on Rab5a-coupled membranes is due to enhanced recruitment, the conformational changes in VPS34 seen in the cryo-ET suggest that activation involves multiple steps.…”
Section: Discussionsupporting
confidence: 90%
“…Here we have described how HDX-MS can be utilized to rapidly identify epitopes for nanobodies and stabilizing conformational changes induced upon binding. HDX-MS is a well-established technique for efficiently defining antibody-binding sites for biopharmaceuticals (Berkowitz et al, 2012) and has been used to define nanobody-binding sites (Buckles et al, 2020;Rostislavleva et al, 2015). The identification of the NB1-PIK3R5 nanobody, which stabilized the dynamic C terminus of the p101 subunit, allowed us to obtain a high-resolution map of the p110g-p101 complex by cryo-EM, which is described in depth in another article.…”
Section: Discussionmentioning
confidence: 99%
“…Here we have described how HDX-MS can be utilized to rapidly identify epitopes for nanobodies and stabilizing conformational changes induced upon binding. HDX-MS is a well-established technique for efficiently defining antibody binding sites for biopharmaceuticals (Berkowitz et al, 2012), and has been used to define nanobody binding sites (Buckles et al, 2020; Rostislavleva et al, 2015). The identification of the NB1-PIK3R5 nanobody, which stabilized the dynamic C-terminus of the p101 subunit, allowed us to obtain a high resolution map of the p110 γ -p101 complex by cryo-EM, which is described in depth in another manuscript.…”
Section: Discussionmentioning
confidence: 99%